Strategic Pharmaceutical Advisors

In an effort to improve the management of asthma and other respiratory diseases, Delmedica Investments introduces a device that measures the temperature of exhaled breath.

Strategic BioSciences and Sinol USA announced today their intent to enter into a definitive agreement to develop and market a new formulation of SINOL Nasal Sprays with MucoAd™, a patented liquid mucoadhesive carrier.

MucoAd™, a non-irritative methylcellulose solution with mucoadhesive properties delayed nasal mucociliary clearance in human subjects, a finding which may have desirable outcomes for administering intranasally-applied medications.

Strategic Pharmaceutical Advisors (SRxA), a leading U.S. healthcare strategic marketing consulting and education firm proudly announced the formation of its European affiliate Strategic Respiratory Advisors – Europe (SRxA–Europe).

Strategic Pharmaceutical Advisors (SRxA) proudly announces the addition of M. Jennifer Derebery, MD as Vice President of Strategic Ear, Nose & Throat Advisors (SENTA), a SRxA affiliated company.